endocrine disease and metabolic disease
Conditions
Interventions
Take an additional 20 ml of blood at the same time as the blood test
Sponsors
Yamaguchi University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who visited our outpatient department and were diagnosed with an endocrine metabolic disease Among them, patients for whom genetic abnormalities were not evident even after conducting tests for gene mutations that can be tested at the time of research protocol creation 2)Patients aged 16 years or older at the time of informed consent 3)regardless gender 4)Patients who obtained written consent from the patient's own free will or proxy consent after receiving sufficient explanation about participating in this study
Exclusion criteria
Exclusion criteria: Patients who are judged to be inappropriate as research subjects by the investigator (co-investigator)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To discover genes responsible for endocrine metabolic diseases and disease-related genes. | — |
Secondary
| Measure | Time frame |
|---|---|
| To elucidate the pathophysiology and causes of individual patient diseases. | — |
Countries
Japan
Contacts
Public ContactYuko Nagao
Yamaguchi University Graduate School of Medicine Department of Endocrinology, Metabolism, Hematological Science and Therapeutics
Outcome results
None listed